WebJul 30, 2013 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that … WebNov 26, 2013 · Cubist Pharmaceuticals is a biopharmaceutical company with activities spanning from research and development to commercialization of pharmaceutical products. Its main products address unmet medical needs in acute care, specifically pathogens like MRSA. Cubist is one of the few firms that have continued to research in antibiotics while …
Search Orphan Drug Designations and Approvals - Food and Drug ...
WebMar 27, 2024 · Email Address Password ... Determine whether Cubist Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Cubist Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry ... WebOct 21, 2013 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s web … north park lincoln san antonio parts
Cubist Pharmaceuticals LLC Company Profile Lexington, …
WebJul 30, 2013 · Cubist Pharmaceuticals, Inc. Eileen C. McIntyre, 781-860-8533 Vice President, Investor Relations [email protected] or MEDIA: Julie DiCarlo, 781-860-8063 Senior Director, Corporate Communications [email protected] or Trius Therapeutics Contacts: MEDIA: MSLGROUP Laura Kempke, 781-684-0770 … WebFeb 25, 2014 · Cubist Pharmaceuticals LLC: ClinicalTrials.gov Identifier: NCT02070757 Other Study ID Numbers: 7625A-008 CXA-NP-11-04 ( Other Identifier: Cubist Protocol Number ) 163338 ( Registry Identifier: JAPIC-CTI ) MK-7625A-008 ( Other Identifier: Merck Protocol Number ) First Posted: February 25, 2014 Key Record Dates Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion). See more Cubist was founded in May 1992 by John K. Clarke, Paul R. Schimmel, Ph.D. and Barry M. Bloom, Ph.D, all of whom were also directors. Cubist appeared on Fortune 2010’s List of fastest growing companies, and was named to … See more The company developed Cubicin (daptomycin) for injection, the first antibiotic in a class of anti-infectives called lipopeptides. In 2011, Cubist settled a patent litigation with Teva Pharmaceutical Industries regarding Cubicin. In April 2011 it reached a deal … See more north park mall dallas texas amc theaters